Thursday, 15 October 2026European Markets

PROXIMUS And TELENOR Have A High Dividend Yield And Return On Equity In The Telecom Services Industry.

Loading stream...

(VIANEWS) - PROXIMUS (PROX.BR) is among this list of stock assets with the highest dividend rate and return on equity on the Telecom Services industry.

Financial Asset Price Forward Dividend Yield Return on Equity
PROXIMUS (PROX.BR) €7.40 18.46% 13.04%
TELENOR (TEL.OL) kr122.00 6.93% 28.47%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. PROXIMUS (PROX.BR)

18.46% Forward Dividend Yield and 13.04% Return On Equity

Proximus PLC provides digital services and communication solutions in Belgium and internationally. It operates through Domestic, International Carrier Services, and TeleSign segments. The company offers fixed and mobile telephony, internet, and television services to residential customers and small businesses, and ICT services to residential, business, and telecom wholesale markets. It also provides managed and platform, integrating networking, cloud, cybersecurity, business application, and data and artificial intelligence services. In addition, the company offers international delivery authentication and digital identity services to internet brands, digital champions, and cloud native businesses. It offers its products and services under Proximus, Scarlet, Mobile Vikings, Tango, Telindus, and Telindus Netherlands brands. The company was formerly known as Belgacom SA and changed its name to Proximus PLC in June 2015. Proximus PLC was founded in 1930 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, PROXIMUS has a trailing twelve months EPS of €1.29.

PE Ratio

PROXIMUS has a trailing twelve months price to earnings ratio of 5.73. Meaning, the purchaser of the share is investing €5.73 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.04%.

Sales Growth

PROXIMUS's sales growth for the current quarter is 1%.

More news about PROXIMUS.

2. TELENOR (TEL.OL)

6.93% Forward Dividend Yield and 28.47% Return On Equity

Telenor ASA, together with its subsidiaries, operates as a telecommunication company worldwide. The company's mobile communication services comprise voice, data, Internet, and content services, as well as customer equipment and messaging. Its fixed services consist of telephony, Internet and TV, and leased lines, as well as data and managed services; and broadcasting and data communication services through satellite, terrestrial radio, and TV transmission. The company also provides machine-to-machine communication, as well as internet based services. Telenor ASA was founded in 1855 and is headquartered in Fornebu, Norway.

Earnings Per Share

As for profitability, TELENOR has a trailing twelve months EPS of kr2.9.

PE Ratio

TELENOR has a trailing twelve months price to earnings ratio of 42.07. Meaning, the purchaser of the share is investing kr42.07 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.47%.

Volatility

TELENOR's last week, last month's, and last quarter's current intraday variation average was a negative 0.42%, a negative 0.09%, and a positive 0.89%.

TELENOR's highest amplitude of average volatility was 0.42% (last week), 0.83% (last month), and 0.89% (last quarter).

More news about TELENOR.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com